Activation of the adaptive immune system via various receptors, different interleukins and its receptors, and the Janus kinases (JAK) STAT pathway

(a) Activation of the adaptive immune system via various receptors, different interleukins and its receptors, and the Janus kinases (JAK) STAT pathway. JAK1, Janus kinase 1; JAK2, Janus kinase 2; JAK3, Janus kinase 3; TYK2, Tyrosine kinase 2; STAT1, Signal transducer and activator of transcription 1; STAT3, Signal transducer and activator of transcription 3; STAT4, Signal transducer and activator of transcription 4; STAT5, Signal transducer and activator of transcription 5; STAT6, Signal transducer and activator of transcription 6; SYK, Spleen tyrosine kinase; BTK, Bruton’s tyrosine kinase; AHR, Aryl-hydrocarbon receptor; TRPA1, Transient receptor cation ankyrin 1; CB1R, Cannabinoid type 1 receptor; CB2R, Cannabinoid type 2 receptor; LXR, Liver X receptor; STAT, Signal transducer and activator of transcription; PDE4, Phosphodiesterase-4; PAR2, Protease-activated receptor 2; H4R, Histamine 4 receptor; S1PR, Sphingosine-1-phosphate receptor. This figure was created with Biorender at www.biorender.com. (b) Mechanism of action of different drugs acting on the adaptive immune system via various receptors, different interleukins and its receptors, and the Janus kinases (JAK) STAT pathway. Dupilumab is a fully humanized monoclonal antibody targeting IL4Rα receptor. CBP201 is a human IgG4 monoclonal antibody that binds to IL-4Rα receptor. AK120 is an antibody against IL4Rα receptor. Tralokinumab and cendakimab, a fully humanized IgG4λ, bind to IL-13 at an epitope that overlaps with the binding site of receptors IL13Rαl subunit and IL13Rα2 subunit. Tezepelumab is an anti-TSLP antibody. Lebrikizumab, a humanized monoclonal IgG4 antibody that selectively blocks IL13 and prevents heterodimerization of type II IL4R receptor composed of IL4Rα and IL13Rαl subunit. Eblasakimab is a fully humanized monoclonal antibody that targets the IL-13Rα1 subunit, therefore inhibiting the signals by IL4 and IL-13. Mepolizumab, a humanized immunoglobulin G monoclonal antibody, binds to interleukin-5, inhibiting its activity. Benralizumab directly binds to the IL-5Rα chain to inhibit the signaling pathway. Nemolizumab, a humanized monoclonal antibody that antagonizes IL-31RA receptor. Vixarelimab, a first-in-class fully human monoclonal antibody that targets oncostatin M receptor. Fezakinumab is an anti-IL-22 monoclonal antibody. Ruxolitinib, baricitinib, and ivarmacitinib inhibit JAK1 and JAK2. Tofacitinib is an inhibitor of JAK1, JAK2, and JAK3. Delgocitinib and jaktinib are pan-jak inhibitors inhibiting JAK1, JAK2, JAK3, and TYK2. Brepocitinib is a selective JAK-1 and TYK-2 inhibitor. Ifidacitinib selectively targets JAK1 and JAK3. Upadacitinib, abrocotinib, and ivarmacitinib are JAK inhibitors with a higher potency for JAK-1. Gusacitinib is a dual JAK-SYK inhibitor. PRN473 is a covalent BTK inhibitor. Branebrutinib is a highly selective BTK inhibitor that covalently binds to the cysteine residue of BTK. Tapinarof is an AHR agonist. HC-030031 and GRC17536 are both TRPA1 antagonists. S-777469 is a CB2R agonist. VTP-38543 and ALX-101 are LXR-β agonists. Crisaborole, PF-07038124, Hemay-808, difamilast, and roflumilast are PDE4 inhibitors in topical forms, while apremilast and orismilast are PDE4 inhibitors in oral form. Methylbenzyl methylbenzimidazole piperidinyl methanone (MMP) is a selective PAR-2 inhibitor in topical form. JNJ 39758979, adriforant, and LEO 152020 are H4R antagonists. KRO-105714 is a dual antagonist of sphingosylphosphorylcholine and sphingosine-1-phosphate receptor 1 in topical form. JTE-013 is an S1PR2 antagonist in topical form. Etrasimod, LC51-0255, and udifitimod are oral S1PR modulators. SCD-044 is an S1PR1 agonist. JAK1, Janus kinase 1; JAK2, Janus kinase 2; JAK3, Janus kinase 3; TYK2, Tyrosine kinase 2; STAT1, Signal transducer and activator of transcription 1; STAT3, Signal transducer and activator of transcription 3; STAT4, Signal transducer and activator of transcription 4; STAT5, Signal transducer and activator of transcription 5; STAT6, Signal transducer and activator of transcription 6; SYK, Spleen tyrosine kinase; BTK, Bruton’s tyrosine kinase; AHR, Aryl-hydrocarbon receptor; TRPA1, Transient receptor cation ankyrin 1; CB1R, Cannabinoid type 1 receptor; CB2R, Cannabinoid type 2 receptor; LXR, Liver X receptor; STAT, Signal transducer and activator of transcription; PDE4, Phosphodiesterase-4; PAR2, Protease-activated receptor 2; H4R, Histamine 4 receptor; S1PR, Sphingosine-1-phosphate receptor. This figure was created with Biorender at www.biorender.com
 Activation of the adaptive immune system via various receptors, different interleukins and its receptors, and the Janus kinases (JAK) STAT pathway

Publication

Challenges and Future Trends in Atopic Dermatitis (2023) Julius Garcia Gatmaitan, et al. Int J Mol Sci. 2023 Jul;24(14). Figure: F3.

Gene mentions


Organism Group Word Match Source NCBI Symbol NCBI ID
Homo sapiens Primates IL-4 IL-4 ncbigene_synonym IL4 3565
Homo sapiens Primates IL-13 IL-13 ncbigene_synonym IL13 3596
Homo sapiens Primates LAR LAR ncbigene_synonym PTPRF 5792
Homo sapiens Primates TH1 TH1 ncbigene_synonym NELFCD 51497
Homo sapiens Primates TSLP TSLP ncbigene_symbol TSLP 85480
Homo sapiens Primates IL-31 IL-31 ncbigene_synonym IL31 386653
Homo sapiens Primates IL-12 IL12 famplex_relations IL12A 3592
Homo sapiens Primates IL-12 IL12 famplex_relations IL12B 3593
Homo sapiens Primates IL-22 IL-22 ncbigene_synonym IL22 50616
Homo sapiens Primates IL-4Ra IL-4RA ncbigene_synonym IL4R 3566
Homo sapiens Primates TSLPR TSLPR ncbigene_synonym CRLF2 64109
Homo sapiens Primates IL-13Ra1 IL13RA1 ncbigene_symbol IL13RA1 3597
Homo sapiens Primates IL31RA IL31RA ncbigene_symbol IL31RA 133396
Homo sapiens Primates OSMRB OSMRB ncbigene_synonym OSMR 9180
Homo sapiens Primates IL-22R IL22R ncbigene_synonym IL22RA1 58985
Homo sapiens Primates IL-10R2 IL-10R2 ncbigene_synonym IL10RB 3588
Homo sapiens Primates JAK1 JAK1 ncbigene_symbol JAK1 3716
Homo sapiens Primates JAK2) JAK2 ncbigene_symbol JAK2 3717
Homo sapiens Primates TYK2 TYK2 ncbigene_symbol TYK2 7297
Homo sapiens Primates (JAK3 JAK3 ncbigene_symbol JAK3 3718
Homo sapiens Primates SYK SYK ncbigene_symbol SYK 6850
Homo sapiens Primates BTK BTK ncbigene_symbol BTK 695
Homo sapiens Primates STAT6 STAT6 ncbigene_symbol STAT6 6778
Homo sapiens Primates STAT3 STAT3 ncbigene_symbol STAT3 6774
Homo sapiens Primates STAT1 STAT1 ncbigene_symbol STAT1 6772
Homo sapiens Primates STAT4 STAT4 ncbigene_symbol STAT4 6775
Homo sapiens Primates AHR AHR ncbigene_symbol AHR 196
Homo sapiens Primates TRPA1 TRPA1 ncbigene_symbol TRPA1 8989
Homo sapiens Primates CB1R CB1R ncbigene_synonym CNR1 1268
Homo sapiens Primates STAT STAT ncbigene_synonym SOAT1 6646
Homo sapiens Primates STAT STAT famplex_relations STAT2 6773
Homo sapiens Primates STAT STAT famplex_relations STAT5A 6776
Homo sapiens Primates STAT STAT famplex_relations STAT5B 6777
Homo sapiens Primates PDE4 PDE4 ncbigene_synonym PDE4A 5141
Homo sapiens Primates PDE4 PDE4 famplex_relations PDE4B 5142
Homo sapiens Primates PDE4 PDE4 famplex_relations PDE4C 5143
Homo sapiens Primates PDE4 PDE4 famplex_relations PDE4D 5144
Homo sapiens Primates IL-17 IL-17 ncbigene_synonym IL17A 3605
Homo sapiens Primates PAR2 PAR2 ncbigene_synonym F2RL1 2150
Homo sapiens Primates PAR2 PAR2 ncbigene_synonym NR1I2 8856
Homo sapiens Primates PAR2 PAR2 ncbigene_synonym SLC52A1 55065
Homo sapiens Primates H4R H4R ncbigene_synonym HRH4 59340
Homo sapiens Primates ATP ATP ncbigene_synonym ATP8A2 51761
Homo sapiens Primates LXR LXR famplex_relations NR1H2 7376
Homo sapiens Primates LXR LXR famplex_relations NR1H3 10062
Homo sapiens Primates IL-5 IL-5 ncbigene_synonym IL5 3567
Homo sapiens Primates IL-13Ra2 IL13RA2 ncbigene_symbol IL13RA2 3598
Homo sapiens Primates IL-7Ra IL-7RA ncbigene_synonym IL7R 3575
Homo sapiens Primates MMP MMP famplex_relations MMP1 4312
Homo sapiens Primates MMP MMP famplex_relations MMP2 4313
Homo sapiens Primates MMP MMP famplex_relations MMP3 4314
Homo sapiens Primates MMP MMP famplex_relations MMP7 4316
Homo sapiens Primates MMP MMP famplex_relations MMP8 4317
Homo sapiens Primates MMP MMP famplex_relations MMP9 4318
Homo sapiens Primates MMP MMP famplex_relations MMP10 4319
Homo sapiens Primates MMP MMP famplex_relations MMP11 4320
Homo sapiens Primates MMP MMP famplex_relations MMP12 4321
Homo sapiens Primates MMP MMP famplex_relations MMP13 4322
Homo sapiens Primates MMP MMP famplex_relations MMP14 4323
Homo sapiens Primates MMP MMP famplex_relations MMP15 4324
Homo sapiens Primates MMP MMP famplex_relations MMP16 4325
Homo sapiens Primates MMP MMP famplex_relations MMP17 4326
Homo sapiens Primates MMP MMP famplex_relations MMP19 4327
Homo sapiens Primates MMP MMP famplex_relations MMP20 9313
Homo sapiens Primates MMP MMP famplex_relations MMP21 118856
Homo sapiens Primates MMP MMP famplex_relations MMP23B 8510
Homo sapiens Primates MMP MMP famplex_relations MMP24 10893
Homo sapiens Primates MMP MMP famplex_relations MMP25 64386
Homo sapiens Primates MMP MMP famplex_relations MMP26 56547
Homo sapiens Primates MMP MMP famplex_relations MMP27 64066
Homo sapiens Primates MMP MMP famplex_relations MMP28 79148
Homo sapiens Primates DOS DOS ncbigene_synonym CBARP 255057
Homo sapiens Primates LCS1-25 LCS1 ncbigene_symbol LCS1 84565

Chemical mentions

Word Match MeSH Name ChEBI
ATP ATP ATP chebi:30616
CAMP cAMP adenosine 3',5'-(hydrogen phosphate) chebi:17489
Ruxolitinib ruxolitinib (3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile chebi:66919
Baricitinib baricitinib {1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile chebi:95341
Tofacitinib tofacitinib 3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile chebi:71200
Roflumilast roflumilast 3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide chebi:47657
Apremilast apremilast N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide chebi:78540
CAMP cAMP adenosine 3',5'-(hydrogen phosphate) chebi:17489
Etrasimod etrasimod [(3R)-7-{[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy}-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acid chebi:229230

Disease mentions

Word Match MeSH Name DOID